These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 30551392)

  • 1. Low serum levels of CCL2 are associated with worse prognosis in patients with Acute Coronary Syndrome: 2-year survival analysis.
    Leocádio PCL; Menta PLDR; Dias MTS; Fraga JR; Goulart AC; Santos IS; Lotufo PA; Bensenor IM; Alvarez-Leite JI
    Biomed Pharmacother; 2019 Jan; 109():1411-1416. PubMed ID: 30551392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Serum Netrin-1 and IL-1β in Elderly Females with ACS: Worse Prognosis in 2-years Follow-up.
    Leocádio P; Menta P; Dias M; Fraga J; Goulart A; Santos I; Lotufo P; Bensenor I; Alvarez-Leite J
    Arq Bras Cardiol; 2020; 114(3):507-514. PubMed ID: 32267322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of fetuin-A and C-reactive protein concentrations for prediction of outcome in acute coronary syndromes (from the French Registry of Acute ST-Elevation Non-ST-Elevation Myocardial Infarction [FAST-MI]).
    Lim P; Moutereau S; Simon T; Gallet R; Probst V; Ferrieres J; Gueret P; Danchin N
    Am J Cardiol; 2013 Jan; 111(1):31-7. PubMed ID: 23062316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Lindberg S; Pedersen SH; Mogelvang R; Jensen JS; Flyvbjerg A; Galatius S; Magnusson NE
    J Am Coll Cardiol; 2012 Jul; 60(4):339-45. PubMed ID: 22813613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of nitrotyrosine levels in coronary heart disease: long-term evaluation in the Acute Coronary Syndrome Registry Strategy (ERICO study).
    Quidim AVL; Bruno T; Leocádio PCL; Santos IS; Alvarez-Leite JI; Dos Reis Menta PL; Lotufo PA; Benseñor IM; Goulart AC
    Clin Biochem; 2019 Apr; 66():37-43. PubMed ID: 30776353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of pre-existing inflammation on the outcome of acute coronary syndrome: a cross-sectional study.
    Odeberg J; Freitag M; Forssell H; Vaara I; Persson ML; Odeberg H; Halling A; Råstam L; Lindblad U
    BMJ Open; 2016 Jan; 6(1):e009968. PubMed ID: 26758266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaemia to predict outcome in patients with acute coronary syndromes.
    Ennezat PV; Maréchaux S; Pinçon C; Finzi J; Barrailler S; Bouabdallaoui N; Van Belle E; Montalescot G; Collet JP
    Arch Cardiovasc Dis; 2013; 106(6-7):357-65. PubMed ID: 23806304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial.
    de Lemos JA; Morrow DA; Blazing MA; Jarolim P; Wiviott SD; Sabatine MS; Califf RM; Braunwald E
    J Am Coll Cardiol; 2007 Nov; 50(22):2117-24. PubMed ID: 18036447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the long-term prognostic value of cystatin C to other indicators of renal function, markers of inflammation and systolic dysfunction among patients with acute coronary syndrome.
    Kilic T; Oner G; Ural E; Yumuk Z; Sahin T; Bildirici U; Acar E; Celikyurt U; Kozdag G; Ural D
    Atherosclerosis; 2009 Dec; 207(2):552-8. PubMed ID: 19523634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of High Risk for Obstructive Sleep Apnea on Survival after Acute Coronary Syndrome: Insights from the ERICO Registry.
    Maia FC; Goulart AC; Drager LF; Staniak HL; Santos IS; Lotufo PA; Bensenor IM
    Arq Bras Cardiol; 2017 Jan; 108(1):31-37. PubMed ID: 28146212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up.
    Marcucci R; Gori AM; Paniccia R; Giusti B; Valente S; Giglioli C; Buonamici P; Antoniucci D; Abbate R; Gensini GF
    Circulation; 2009 Jan; 119(2):237-42. PubMed ID: 19118249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between red blood cell distribution width and outcomes at six months in patients with acute coronary syndromes.
    Nabais S; Losa N; Gaspar A; Rocha S; Costa J; Azevedo P; Basto L; Pereira MA; Correia A
    Rev Port Cardiol; 2009 Sep; 28(9):905-24. PubMed ID: 19998803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth-differentiation factor 15 for long-term prognostication in patients with non-ST-elevation acute coronary syndrome: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy.
    Damman P; Kempf T; Windhausen F; van Straalen JP; Guba-Quint A; Fischer J; Tijssen JG; Wollert KC; de Winter RJ; Hirsch A;
    Int J Cardiol; 2014 Mar; 172(2):356-63. PubMed ID: 24502880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase-2 predicts mortality in patients with acute coronary syndrome.
    Dhillon OS; Khan SQ; Narayan HK; Ng KH; Mohammed N; Quinn PA; Squire IB; Davies JE; Ng LL
    Clin Sci (Lond); 2009 Nov; 118(4):249-57. PubMed ID: 19583569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease.
    Kastrup J; Johansen JS; Winkel P; Hansen JF; Hildebrandt P; Jensen GB; Jespersen CM; Kjøller E; Kolmos HJ; Lind I; Nielsen H; Gluud C;
    Eur Heart J; 2009 May; 30(9):1066-72. PubMed ID: 19270316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship and prognostic importance of thyroid hormone and N-terminal pro-B-Type natriuretic peptide for patients after acute coronary syndromes: a longitudinal observational study.
    Brozaitiene J; Mickuviene N; Podlipskyte A; Burkauskas J; Bunevicius R
    BMC Cardiovasc Disord; 2016 Feb; 16():45. PubMed ID: 26892923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term cardiovascular mortality after procedure-related or spontaneous myocardial infarction in patients with non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II, ICTUS, and RITA-3 trials (FIR).
    Damman P; Wallentin L; Fox KA; Windhausen F; Hirsch A; Clayton T; Pocock SJ; Lagerqvist B; Tijssen JG; de Winter RJ
    Circulation; 2012 Jan; 125(4):568-76. PubMed ID: 22199015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
    Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of Plasma Matrix Metalloproteinase-3 Levels to Predict Myocardial Infarction in Men With and Without Acute Coronary Syndrome.
    Cavusoglu E; Marmur JD; Kassotis JT; Yanamadala S; Chopra V; Eng C
    Am J Cardiol; 2016 Mar; 117(6):881-6. PubMed ID: 26805660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of carotid intima-media in the short- and long-term mortality in the Strategy of Registry of Acute Coronary Syndrome (ERICO) study.
    Meireles DP; Santos IS; Alencar AP; Lotufo PA; Benseñor IM; Goulart AC
    Echocardiography; 2018 Sep; 35(9):1351-1361. PubMed ID: 29886570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.